Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$1.15 - $2.53 $97,898 - $215,376
-85,129 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$1.91 - $3.98 $15,709 - $32,735
8,225 Added 10.7%
85,129 $180,000
Q4 2021

Feb 07, 2022

BUY
$3.53 - $5.5 $105,021 - $163,630
29,751 Added 63.09%
76,904 $306,000
Q3 2021

Nov 04, 2021

BUY
$4.99 - $6.55 $6,402 - $8,403
1,283 Added 2.8%
47,153 $235,000
Q2 2021

Aug 06, 2021

SELL
$6.24 - $8.22 $79,834 - $105,166
-12,794 Reduced 21.81%
45,870 $299,000
Q1 2021

May 06, 2021

BUY
$6.74 - $10.95 $126,368 - $205,301
18,749 Added 46.97%
58,664 $404,000
Q4 2020

Feb 09, 2021

BUY
$3.75 - $10.56 $149,681 - $421,502
39,915 New
39,915 $407,000
Q2 2020

Aug 06, 2020

SELL
$2.16 - $5.46 $66,482 - $168,053
-30,779 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$1.46 - $7.19 $44,937 - $221,301
30,779 New
30,779 $105,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $329M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.